Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
64.92 USD | +0.22% | -1.81% | -20.08% |
May. 02 | UBS Adjusts Price Target on Gilead Sciences to $70 From $75, Maintains Neutral Rating | MT |
May. 01 | Deutsche Bank Adjusts Price Target on Gilead Sciences to $73 From $75 | MT |
Financials (USD)
Sales 2024 * | 27.59B | Sales 2025 * | 27.97B | Capitalization | 80.78B |
---|---|---|---|---|---|
Net income 2024 * | 406M | Net income 2025 * | 6.44B | EV / Sales 2024 * | 3.59 x |
Net Debt 2024 * | 18.15B | Net Debt 2025 * | 12.68B | EV / Sales 2025 * | 3.34 x |
P/E ratio 2024 * |
183
x | P/E ratio 2025 * |
12.4
x | Employees | 18,000 |
Yield 2024 * |
4.77% | Yield 2025 * |
5.01% | Free-Float | 99.9% |
Latest transcript on Gilead Sciences, Inc.
1 day | -0.19% | ||
1 week | -1.71% | ||
Current month | -0.60% | ||
1 month | -6.64% | ||
3 months | -16.61% | ||
6 months | -20.13% | ||
Current year | -20.00% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 59 | 19-02-28 |
Andrew Dickinson
DFI | Director of Finance/CFO | 54 | 15-12-31 |
Flavius Martin
CTO | Chief Tech/Sci/R&D Officer | - | 21-04-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anthony Welters
BRD | Director/Board Member | 69 | 20-10-16 |
Director/Board Member | 71 | 17-12-31 | |
Ted Love
BRD | Director/Board Member | 65 | Jan. 31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
13.99% | 215 M€ | +9.77% | - | |
8.10% | 0 M€ | 0.00% | - | |
8.06% | 0 M€ | 0.00% | - | |
5.23% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 64.82 | +0.06% | 2 447 309 |
24-05-03 | 64.78 | -0.84% | 7,822,720 |
24-05-02 | 65.33 | -0.27% | 5,571,500 |
24-05-01 | 65.51 | +0.48% | 7,232,520 |
24-04-30 | 65.2 | -1.12% | 7,436,603 |
Delayed Quote Nasdaq, May 06, 2024 at 12:16 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.00% | 80.78B | |
+28.50% | 662B | |
+22.23% | 546B | |
-4.93% | 359B | |
+16.97% | 323B | |
+4.08% | 289B | |
+13.68% | 234B | |
+3.84% | 198B | |
-10.35% | 194B | |
+3.98% | 167B |
- Stock Market
- Equities
- GILD Stock